BRADLEY HUGHES, M.D.
Retina Specialist (Ophthalmology) Physician · LITTLE ROCK, AR
Individual Active NPI 1184633075
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,443 | 33,904 | $8,541,698 | $3,181,198 | $2,502,031 |
| 2023 | 1,433 | 27,088 | $7,441,363 | $2,766,090 | $2,159,680 |
| 2022 | 1,450 | 13,657 | $7,221,466 | $2,785,572 | $2,174,914 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 22,320 | $34 | $27 |
| 92134 | Imaging of retina | 3,120 | $36 | $27 |
| 67028 | Injection of drug into eye | 1,726 | $101 | $76 |
| J0178 | Injection, aflibercept, 1 mg | 1,524 | $827 | $657 |
| 92012 | Established patient problem focused exam of visual system | 1,454 | $79 | $58 |
| J0177 | Injection, aflibercept hd, 1 mg | 840 | $331 | $264 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 840 | $108 | $86 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 540 | $147 | $117 |
| 92014 | Established patient complete exam of visual system | 373 | $112 | $80 |
| J7999 | Compounded drug, not otherwise classified | 350 | $84 | $66 |
| J2778 | Injection, ranibizumab, 0.1 mg | 265 | $160 | $126 |
| 92004 | New patient complete exam of visual system | 264 | $134 | $101 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ✓ | E4375 | AR |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Retina Specialist (Ophthalmology) Physician providers in Arkansas
- NPI 1235345414
- NPI 1730161373
- NPI 1851373484
- NPI 1255350021
- NPI 1235690264
- NPI 1205702883
- NPI 1174729016
- NPI 1346736337
See all Retina Specialist (Ophthalmology) Physician providers in Arkansas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.